Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' STEWARD WP' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 66 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Sharma, RA; Steward, WP; West, KP; Hemingway, D
      Toxic megacolon: remember cytomegalovirus

      HOSPITAL MEDICINE
    2. Sharma, RA; McLelland, HR; Hill, KA; Ireson, CR; Euden, SA; Manson, MM; Pirmohamed, M; Marnett, LJ; Gescher, AJ; Steward, WP
      Pharmacodynamic and pharmacokinetic study of oral Curcuma extract in patients with colorectal cancer

      CLINICAL CANCER RESEARCH
    3. Levitt, NC; Eskens, FALM; O'Byrne, KJ; Propper, DJ; Denis, LJ; Owen, SJ; Choi, L; Foekens, JA; Wilner, S; Wood, JM; Nakajima, M; Talbot, DC; Steward, WP; Harris, AL; Verweij, J
      Phase I and pharmacological study of the oral matrix metalloproteinase inhibitor, MMI270 (CGS27023A), in patients with advanced solid cancer

      CLINICAL CANCER RESEARCH
    4. Sharma, RA; Ireson, CR; Verschoyle, RD; Hill, KA; Williams, ML; Leuratti, C; Manson, MM; Marnett, LJ; Steward, WP; Gescher, A
      Effects of dietary curcumin on glutathione S-transferase and malomdialdehyde-DNA adducts in rat liver and colon mucosa: Relationship with drug levels

      CLINICAL CANCER RESEARCH
    5. Sharma, RA; Manson, MM; Gescher, A; Steward, WP
      Colorectal cancer chemoprevention: biochemical targets and clinical development of promising agents

      EUROPEAN JOURNAL OF CANCER
    6. Sharma, RA; Symonds, RP; O'Byrne, KJ; Cheater, F; Abrams, KR; Steward, WP
      Involving patients in treatment decisions: Can we learn from clinical trials?

      CLINICAL ONCOLOGY
    7. Thomas, AL; O'Byrne, K; Furber, L; Jeffery, K; Steward, WP
      A phase II study of Caelyx, liposomal doxorubicin: lack of activity in patients with advanced gastric cancer

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    8. Sharma, RA; Eatock, MM; Twelves, CJ; Brown, G; McLelland, HR; Clayton, KT; O'Byrne, KJ; Moyses, C; Carmichael, J; Steward, WP
      Bioavailability study of oral and intravenous OGT 719, a novel nucleoside analogue with preferential activity in the liver

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    9. Sharma, RA; Gescher, A; Plastaras, JP; Leuratti, C; Singh, R; Gallacher-Horley, B; Offord, E; Marnett, LJ; Steward, WP; Plummer, SM
      Cyclooxygenase-2, malondialdehyde and pyrimidopurinone adducts of deoxyguanosine in human colon cells

      CARCINOGENESIS
    10. Sharma, RA; Gescher, AJ; O'Byrne, KJ; Steward, WP
      Familiar drugs may prevent cancer

      POSTGRADUATE MEDICAL JOURNAL
    11. O'Byrne, KJ; Schally, AV; Thomas, A; Carney, DN; Steward, WP
      Somatostatin, its receptors and analogs, in lung cancer

      CHEMOTHERAPY
    12. Ireson, C; Orr, S; Jones, DJL; Verschoyle, R; Lim, CK; Luo, JL; Howells, L; Plummer, S; Jukes, R; Williams, M; Steward, WP; Gescher, A
      Characterization of metabolites of the chemopreventive agent curcumin in human and rat hepatocytes and in the rat in vivo, and evaluation of their ability to inhibit phorbol ester-induced prostaglandin E-2 production

      CANCER RESEARCH
    13. Thomas, AL; Steward, WP
      Marimastat: the clinical development of a matrix metalloproteinase inhibitor

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    14. O'Byrne, KJ; Dalgleish, AG; Browning, MJ; Steward, WP; Harris, AL
      The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease

      EUROPEAN JOURNAL OF CANCER
    15. Thomas, AL; Cox, G; Sharma, RA; Steward, WP; Shields, F; Jeyapalan, K; Muller, S; O'Byrne, KJ
      Gemcitabine and paclitaxel associated pneumonitis in non-small cell lung cancer: report of a phase I/II dose-escalating study

      EUROPEAN JOURNAL OF CANCER
    16. Cox, G; Walker, RA; Andi, A; Steward, WP; O'Byrne, KJ
      Prognostic significance of platelet and microvessel counts in operable non-small cell lung cancer

      LUNG CANCER
    17. Cox, G; Jones, JL; Walker, RA; Steward, WP; O'Byrne, KJ
      Angiogenesis and non-small cell lung cancer

      LUNG CANCER
    18. Thomas, AL; O'Byrne, K; Steward, WP
      Chemotherapy for upper gastrointestinal tumours

      POSTGRADUATE MEDICAL JOURNAL
    19. O'Byrne, KJ; Koukourakis, MI; Giatromanolaki, A; Cox, G; Turley, H; Steward, WP; Gatter, K; Harris, AL
      Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small cell lung cancer

      BRITISH JOURNAL OF CANCER
    20. Thomas, A; Steward, WP
      Gemcitabine: A real major advance? Response

      ANNALS OF ONCOLOGY
    21. Bramwell, VHC; Steward, WP; Nooij, M; Whelan, J; Craft, AW; Grimer, RJ; Taminau, AHM; Cannon, SR; Malcolm, AJ; Hogendoorn, PCW; Uscinska, B; Kirkpatrick, AL; Machin, D; Van Glabbeke, MM
      Neoadjuvant chemotherapy with doxorubicin and cisplatin in malignant fibrous histiocytoma of bone: A European osteosarcoma intergroup study

      JOURNAL OF CLINICAL ONCOLOGY
    22. Steward, WP
      Marimastat (BB2516): Current status of development

      CANCER CHEMOTHERAPY AND PHARMACOLOGY
    23. O'Byrne, KJ; Steward, WP
      The promise of improved drug delivery

      CLINICAL SCIENCE
    24. Cox, G; Steward, WP; O'Byrne, KJ
      The plasmin cascade and matrix metalloproteinases in non-small cell lung cancer

      THORAX
    25. O'Byrne, K; Steward, WP
      The role of chemotherapy in the treatment of adult soft tissue sarcomas

      ONCOLOGY
    26. Thatcher, N; De Campos, ES; Bell, DR; Steward, WP; Varghese, G; Morant, R; Vansteenkiste, JF; Rosso, R; Ewers, SB; Sundal, E; Schatzmann, E; Stocker, H
      Epoetin alpha prevents anaemia and reduces transfusion requirements in patients undergoing primarily platinum-based chemotherapy for small cell lung cancer

      BRITISH JOURNAL OF CANCER
    27. OBYRNE K; STEWARD WP
      THE ROLE OF ADJUVANT CHEMOTHERAPY IN THE TREATMENT OF ADULT SOFT-TISSUE SARCOMAS

      Critical reviews in oncology/hematology
    28. Thomas, A; Steward, WP
      Gemcitabine - a major advance?

      ANNALS OF ONCOLOGY
    29. STEWARD WP; VONPAWEL J; GATZEMEIER U; WOLL P; THATCHER N; KOSCHEL G; CLANCY L; VERWEIJ J; DEWIT R; PFEIFER W; FENNELLY J; VONEIFF M; FRISCH J
      EFFECTS OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AND DOSE INTENSIFICATION OF V-ICE CHEMOTHERAPY IN SMALL-CELL LUNG-CANCER - A PROSPECTIVE RANDOMIZED STUDY OF 300 PATIENTS

      Journal of clinical oncology
    30. DALHOFF K; ASTRUP L; BACHHANSEN J; BURCHARTH F; HAAHR HLO; HAMBERG KJ; EVANS TRJ; LOFTS F; MOLLER S; RANEK L; SKOVSGAARD T; STEWARD WP
      SEOCALCITOL (EB-1089), A VITAMIN-D ANALOG, IN HEPATOCELLULAR-CARCINOMA

      Hepatology
    31. ABRATT RP; SANDLER A; CRINO L; STEWARD WP; SHEPHERD FA; GREEN MR; NGUYEN B; PETERS GJ
      COMBINED CISPLATIN AND GEMCITABINE FOR NONSMALL CELL LUNG-CANCER - INFLUENCE OF SCHEDULING ON TOXICITY AND DRUG-DELIVERY

      Seminars in oncology
    32. STEWARD WP
      COMBINATION STUDIES WITH GEMCITABINE IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER

      British Journal of Cancer
    33. OBYRNE KJ; BEARE S; SHIELDS F; SHARMA R; JEYAPALAN K; STEWARD WP
      PHASE I II DOSE ESCALATING STUDY OF GEMCITABINE AND PACLITAXEL IN NONSMALL CELL LUNG-CANCER (NSCLC) - PRELIMINARY-REPORT/

      British Journal of Cancer
    34. BEARE S; STEWARD WP
      PLASMA-FREE IRON AND CHEMOTHERAPY TOXICITY

      Lancet
    35. STEWARD WP; DUNLOP DJ; DABOUIS G; LACROIX H; TALBOT D
      PHASE I II STUDY OF GEMCITABINE AND CISPLATIN IN THE TREATMENT OF ADVANCED NONSMALL CELL LUNG-CANCER - PRELIMINARY-RESULTS/

      Seminars in oncology
    36. HOLYOAKE TL; ALCORN MJ; RICHMOND L; PEARSON C; FARRELL E; KYLE B; DUNLOP DJ; FITZSIMONS E; STEWARD WP; PRAGNELL IB; FRANKLIN IM
      AN EVALUATION OF THE FEASIBILITY OF USING CD34 POSITIVE CELLS EXPANDED EX-VIVO FOR TRANSPLANTATION

      British Journal of Haematology
    37. HOLYOAKE TL; FRESHNEY MG; MCNAIR L; PARKER AN; MCKAY PJ; STEWARD WP; FITZSIMONS E; GRAHAM GJ; PRAGNELL IB
      EX-VIVO EXPANSION WITH STEM-CELL FACTOR AND INTERLEUKIN-11 AUGMENTS BOTH SHORT-TERM RECOVERY POSTTRANSPLANT AND THE ABILITY TO SERIALLY TRANSPLANT MARROW

      Blood
    38. HATTON MQF; CASSIDY J; BICKNELL S; SEMPLE P; STACK B; STEWARD WP
      IFOSFAMIDE, CARBOPLATIN AND ETOPOSIDE FOR GOOD PROGNOSIS SMALL-CELL LUNG-CANCER - ARE 4 COURSES INADEQUATE

      European journal of cancer
    39. SEYMOUR AM; DECAMPOS E; THATCHER N; DEGREVE J; CUNNINGHAM D; HOWELL A; TUENI E; BRON DG; STEWARD WP; BERDEL WE; KNUTH A; LORENZ J; TIMOTHY AR; YVER A; RICHARDS MA
      A SINGLE-BLIND, RANDOMIZED, VEHICLE-CONTROLLED DOSE-FINDING STUDY OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (LENOGRASTIM) IN PATIENTS UNDERGOING CHEMOTHERAPY FOR SOLID CANCERS AND LYMPHOMA

      European journal of cancer
    40. VASEY PA; DUNLOP DJ; STEWARD WP
      NEPHROGENIC DIABETES-INSIPIDUS FOLLOWING HIGH-DOSE EPIRUBICIN CHEMOTHERAPY FOR METASTATIC SOFT-TISSUE SARCOMA

      European journal of cancer
    41. STEWARD WP
      HIGH-DOSE CHEMOTHERAPY WITH HEMATOPOIETIC SUPPORT FOR BREAST-CANCER

      European journal of cancer
    42. STEWARD WP; VONPAWEL J; GATZEMEIER U; THATCHER N; FRISCH J
      DOSE-INTENSIFICATION OF V-ICE CHEMOTHERAPY WITH GM-CSF IN SMALL-CELL LUNG-CANCER (SCLC) - A PROSPECTIVE RANDOMIZED STUDY OF 301 PATIENTS

      European journal of cancer
    43. STEWARD WP; DUNLOP DJ; CAMERON C; TALBOT DC; KLEISBAUER JL; THOMAS P; GUERIN JC; PEROL M; SANSON C; DABOUIS G; LACROIX H
      GEMCITABINE COMBINED WITH CISPLATIN IN NON-SMALL-CELL LUNG-CANCER (NSCLC) - A PHASE I II STUDY/

      European journal of cancer
    44. DANCEY J; STEWARD WP
      THE ROLE OF VINDESINE IN ONCOLOGY - RECOMMENDATIONS AFTER 10 YEARS EXPERIENCE

      Anti-cancer drugs
    45. STEWARD WP; DUNLOP DJ; CAMERON C; TALBOT DC; KLEISBAUER JP; THOMAS P; GUERIN JC; PEROL M; SANSON C; DABOUIS G; LACROIX H
      COMBINATION CHEMOTHERAPY WITH GEMCITABINE AND CISPLATIN IN THE TREATMENT OF ADVANCED NON-SMALL-CELL LUNG-CANCER - PRELIMINARY-RESULTS OF ANONGOING PHASE I II STUDY/

      Anti-cancer drugs
    46. STEWARD WP; DUNLOP DJ
      NEW DRUGS IN THE TREATMENT OF NON-SMALL-CELL LUNG-CANCER

      Annals of oncology
    47. GOSS G; MULDAL A; LOHMANN R; TAYLOR M; LOPEZ P; ARMITAGE G; STEWARD WP
      DIDEMNIN-B IN FAVORABLE HISTOLOGY NON-HODGKINS-LYMPHOMA - A PHASE-II STUDY OF THE NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP

      Investigational new drugs
    48. ALCORN MJ; HOLYOAKE TL; RICHMOND LJ; PEARSON C; FARRELL E; KYLE B; DUNLOP DJ; FITZSIMONS E; STEWARD WP; PRAGNELL IB; FRANKLIN IM
      CD34 SELECTION USING THE BAXTER-ISOLEX-300 SYSTEM - COMPARISON BETWEEN FRESH PBPC AND CRYOPRESERVED PBPC

      Blood
    49. HOLYOAKE TL; ALCORN MJ; RICHMOND L; PEARSON C; FARRELL E; KYLE B; DUNLOP DJ; FITZSIMONS E; STEWARD WP; PRAGNELL IB; FRANKLIN JM
      A PHASE-I STUDY TO EVALUATE THE SAFETY OF RE-INFUSING CD34 CELLS EXPANDED EX-VIVO AS PART OR ALL OF A PBPC TRANSPLANT PROCEDURE

      Blood
    50. HOLYOAKE TL; ALCORN MJ; RICHMOND LJ; FRESHNEY MG; PEARSON C; FITZSIMONS E; STEWARD WP; DUNLOP DJ; PRAGNELL IB
      EFFICIENT ISOLATION OF HUMAN CD34 POSITIVE HEMATOPOIETIC PROGENITOR CELLS BY IMMUNE PANNING (VOL 12, PG 114-124, 1994)

      Stem cells
    51. HOLYOAKE TL; ALCORN MJ; RICHMOND LJ; FRESHNEY MG; PEARSON C; FITZSIMONS E; STEWARD WP; DUNLOP DJ; PRAGNELL IB
      EFFICIENT ISOLATION OF HUMAN CD34 POSITIVE HEMATOPOIETIC PROGENITOR CELLS BY IMMUNE PANNING

      Stem cells
    52. JODRELL DI; OSTER W; KERR DJ; CANNEY PA; YOSEF H; STEWARD WP; KAYE SB; CASSIDY J
      A PHASE I-II STUDY OF N-(PHOSPHONACETYL)-L-ASPARTIC ACID (PALA) ADDEDTO 5-FLUOROURACIL AND FOLINIC ACID IN ADVANCED COLORECTAL-CANCER

      European journal of cancer
    53. ORNADEL D; SOUHAMI RL; WHELAN J; NOOY M; DEELVIRA CR; PRINGLE J; LEWIS I; STEWARD WP; GEORGE R; BRIDGEWATER J; WIERZBICKI R; CRAFT AW
      DOXORUBICIN AND CISPLATIN WITH GRANULOCYTE-COLONY-STIMULATING FACTOR AS ADJUVANT CHEMOTHERAPY FOR OSTEOSARCOMA - PHASE-II TRIAL OF THE EUROPEAN-OSTEOSARCOMA-INTERGROUP

      Journal of clinical oncology
    54. ALCORN MJ; HOLYOAKE TL; PEARSON C; STEVENSON J; MCKAY P; FITZSIMONS EJ; STEWARD WP; PRAGNEL IB; FRANKLIN IM
      EXPANSION OP CD34-CELLS( CELLS ISOLATED FROM MOBILIZED PERIPHERAL STEM)

      Experimental hematology
    55. HOLYOAKE TL; FRESHNEY MG; MCNAIR L; MCKAY PJ; PARKER A; STEWARD WP; FITZSIMONS E; PRAGNELL IB
      MIP-1-ALPHA APPEARS TO PROMOTE SELF-RENEWAL OF PRIMITIVE MURINE HEMATOPOIETIC PROGENITORS

      Experimental hematology
    56. STEWARD WP
      EFFICACY OF THYMOSTIMULIN

      Lancet
    57. DUNLOP DJ; FITZSIMONS EJ; MCMURRAY A; MORRISON M; KYLE E; ALCORN MJ; STEWARD WP
      FILGRASTIM FAILS TO IMPROVE HEMATOPOIETIC RECONSTITUTION FOLLOWING MYELOABLATIVE CHEMOTHERAPY AND PERIPHERAL-BLOOD STEM-CELL RESCUE

      British Journal of Cancer
    58. HOLYOAKE TL; FRESHNEY MG; SPROUL AM; RICHMOND LJ; ALCORN MJ; STEWARD WP; FITZSIMONS E; DUNLOP DJ; FRANKLIN IM; PRAGNELL IB
      CONTRASTING EFFECTS OF RH-MIP-1-ALPHA AND TGF-BETA(1) ON CHRONIC MYELOID-LEUKEMIA PROGENITORS IN-VITRO

      Stem cells
    59. PRESCOTT RJ; LEONARD RCF; ALLAN NC; ANGUS B; BARRETT A; DAS SN; DAWSON AA; HEPPLESTON A; LESSELLS AM; LUCIE NP; LUCRAFT HH; MACKIE MJ; MACLAREN KS; MATHESON LM; PARKER AC; PROCTOR SJ; SARKAR TK; SOUKOP M; STEWARD WP; WHITE JM
      PILOT-STUDY AND RANDOMIZED TRIAL OF MITOXANTRONE AND IFOSFAMIDE FOR RELAPSED NON-HODGKINS-LYMPHOMA

      Leukemia & lymphoma
    60. CAMERON DA; LEONARD RCF; MAO JH; PRESCOTT RJ; ALLAN NC; BARRETT A; DAS SN; DAWSON AA; HEPPLESTON A; LENNARD AL; LEONARD RCF; LESSELLS AM; LUCIE NP; LUCRAFT HH; MACKIE MJ; MACLAREN KS; MATHESON LM; PARKER AC; PRESCOTT RJ; PROCTOR SJ; ROBERTSON AG; SARKAR TK; SOUKOP M; STEWARD WP; TANSEY PJ; WHITE JM
      IDENTIFICATION OF PROGNOSTIC GROUPS IN FOLLICULAR LYMPHOMA

      Leukemia & lymphoma
    61. STEWARD WP; VANTONGELEN K; VERWEIJ J; THOMAS D; VANOOSTEROM AT
      CHEMOTHERAPY ADMINISTRATION AND DATA-COLLECTION IN AN EORTC COLLABORATIVE GROUP - CAN WE TRUST THE RESULTS

      European journal of cancer
    62. MCLEAY GF; STEWARD WP
      HIGH-GRADE SOFT-TISSUE SARCOMA

      Annals of oncology
    63. HOLYOAKE TL; DUNLOP DJ; FITZSIMONS E; STEWARD WP; PRAGNELL IB
      MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA (MIP-1-ALPHA) ENHANCES HEMATOPOIETIC PROGENITOR EXPANSION IN SUSPENSION-CULTURE

      Experimental hematology
    64. STEWARD WP
      GRANULOCYTE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS - REPLY

      Lancet
    65. STEWARD WP
      GRANULOCYTE AND GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTORS

      Lancet
    66. DUNLOP DJ; CAMPBELL SM; MCNAIR L; HOLYOAKE T; LARSEN F; STEWARD WP
      PHASE-1 1B DOSE-ESCALATION STUDY OF SERASPENIDE (ACSDKP), AN INHIBITOR OF HEMATOPOIETIC STEM-CELL PROLIFERATION, IN PATIENTS WITH ADVANCED SOLID TUMORS/

      Blood


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 22/10/20 alle ore 11:33:24